Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25).
Antman
Elliott M
EM
TIMI Study Group, Boston, MA 02115, USA. eantman@rics.bwh.harvard.edu
Morrow
David A
DA
McCabe
Carolyn H
CH
Jiang
Frank
F
White
Harvey D
HD
Fox
Keith A A
KA
Sharma
Divakar
D
Chew
Paul
P
Braunwald
Eugene
E
D004311:Double-Blind Method; D004562:Electrocardiography; D017984:Enoxaparin / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D015337:Multicenter Studies as Topic; D009203:Myocardial Infarction / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D012107:Research Design; D015912:Thrombolytic Therapy
D017984:Enoxaparin; D005343:Fibrinolytic Agents; D006493:Heparin